{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T06:42:33Z","timestamp":1793169753005,"version":"4.5.0"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"National Research Foundation of Korea (NRF) grant","award":["NRF-2021R1C1C1010575"],"award-info":[{"award-number":["NRF-2021R1C1C1010575"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>The perioperative milieu following curative lung cancer surgery is accompanied by a stress response. Inflammasomes mediate inflammation resulting in the unfavorable immunomodulation of natural killer (NK) cell activity, thus promoting cancer progression. This study aimed to investigate the effects of dexmedetomidine (DEX) on the innate immune system, chronic inflammation, and lung cancer progression in a clinically relevant human-to-mouse xenograft model. The human lung cancer cell line A549-luc was subcutaneously injected into BALB\/c nude mice. Saline or dexmedetomidine was administered for 2\u00a0weeks via an implanted osmotic minipump. After 4\u00a0weeks, the tumor size and weight were measured. NK cell activity, serum interferon-\u03b3, interleukin (IL)-1\u03b2 and tumor necrosis factor (TNF)-\u03b1 levels were also measured. IL-10, IL-18, and inflammasome expression levels were assessed in the tumor tissues. DEX caused a decrease in tumor size, tumor weight, and IL-1\u03b2 and TNF-\u03b1 levels and an increase in NK cell activity and IFN-\u03b3 level. IL-10 and IL-18 expression was significantly decreased in the DEX-treated group. NLRP3, CTP1A, TXNIP, ASC, IL-1\u03b2, and caspase-1 protein levels were decreased in the DEX-treated group. In conclusion, the use of DEX for 2\u00a0weeks inhibited lung cancer progression by suppressing inflammasome- and IL-1\u03b2 signaling-induced inflammation and enhancing NK cell activity.<\/jats:p>","DOI":"10.1038\/s41598-023-39704-3","type":"journal-article","created":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T10:03:53Z","timestamp":1690884233000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Effects of dexmedetomidine on A549 non-small cell lung cancer growth in a clinically relevant surgical xenograft model"],"prefix":"10.1038","volume":"13","author":[{"given":"Ji Hae","family":"Jun","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jae-Kwang","family":"Shim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ju Eun","family":"Oh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kwang-Sub","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Young-Lan","family":"Kwak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5022-4617","authenticated-orcid":false,"given":"Sarah","family":"Soh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,8,1]]},"reference":[{"key":"39704_CR1","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1038\/nrclinonc.2016.144","volume":"14","author":"M Mohme","year":"2017","unstructured":"Mohme, M., Riethdorf, S. & Pantel, K. Circulating and disseminated tumour cells: Mechanisms of immune surveillance and escape. Nat. Rev. Clin. Oncol. 14, 155\u2013167. https:\/\/doi.org\/10.1038\/nrclinonc.2016.144 (2017).","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"39704_CR2","doi-asserted-by":"publisher","first-page":"1636","DOI":"10.1213\/ANE.0b013e3181de0ab6","volume":"110","author":"A Gottschalk","year":"2010","unstructured":"Gottschalk, A., Sharma, S., Ford, J., Durieux, M. E. & Tiouririne, M. Review article: The role of the perioperative period in recurrence after cancer surgery. Anesth. Analg. 110, 1636\u20131643. https:\/\/doi.org\/10.1213\/ANE.0b013e3181de0ab6 (2010).","journal-title":"Anesth. Analg."},{"key":"39704_CR3","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1038\/nrm2455","volume":"9","author":"M Sch\u00e4fer","year":"2008","unstructured":"Sch\u00e4fer, M. & Werner, S. Cancer as an overhealing wound: An old hypothesis revisited. Nat. Rev. Mol. Cell. Biol. 9, 628\u2013638. https:\/\/doi.org\/10.1038\/nrm2455 (2008).","journal-title":"Nat. Rev. Mol. Cell. Biol."},{"key":"39704_CR4","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1186\/s12943-019-1058-3","volume":"18","author":"Z Chen","year":"2019","unstructured":"Chen, Z. et al. Surgical stress and cancer progression: The twisted tango. Mol. Cancer 18, 132. https:\/\/doi.org\/10.1186\/s12943-019-1058-3 (2019).","journal-title":"Mol. Cancer"},{"key":"39704_CR5","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1186\/s13046-020-01688-7","volume":"39","author":"M Liang","year":"2020","unstructured":"Liang, M. et al. Cancer-derived exosomal TRIM59 regulates macrophage NLRP3 inflammasome activation to promote lung cancer progression. J. Exp. Clin. Cancer Res. 39, 176. https:\/\/doi.org\/10.1186\/s13046-020-01688-7 (2020).","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"39704_CR6","doi-asserted-by":"publisher","first-page":"e0205242","DOI":"10.1371\/journal.pone.0205242","volume":"13","author":"I Lasithiotaki","year":"2018","unstructured":"Lasithiotaki, I. et al. NLRP3\/Caspase-1 inflammasome activation is decreased in alveolar macrophages in patients with lung cancer. PLoS ONE 13, e0205242. https:\/\/doi.org\/10.1371\/journal.pone.0205242 (2018).","journal-title":"PLoS ONE"},{"key":"39704_CR7","doi-asserted-by":"publisher","first-page":"5721","DOI":"10.1158\/0008-5472.Can-12-0509","volume":"72","author":"MT Chow","year":"2012","unstructured":"Chow, M. T. et al. NLRP3 suppresses NK cell-mediated responses to carcinogen-induced tumors and metastases. Cancer Res. 72, 5721\u20135732. https:\/\/doi.org\/10.1158\/0008-5472.Can-12-0509 (2012).","journal-title":"Cancer Res."},{"key":"39704_CR8","doi-asserted-by":"publisher","first-page":"107709","DOI":"10.1016\/j.intimp.2021.107709","volume":"97","author":"K Yuki","year":"2021","unstructured":"Yuki, K. The immunomodulatory mechanism of dexmedetomidine. Int. Immunopharmacol. 97, 107709. https:\/\/doi.org\/10.1016\/j.intimp.2021.107709 (2021).","journal-title":"Int. Immunopharmacol."},{"key":"39704_CR9","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1016\/j.bja.2019.07.027","volume":"123","author":"K Wang","year":"2019","unstructured":"Wang, K. et al. Effects of dexmedetomidine on perioperative stress, inflammation, and immune function: Systematic review and meta-analysis. Br. J. Anaesth. 123, 777\u2013794. https:\/\/doi.org\/10.1016\/j.bja.2019.07.027 (2019).","journal-title":"Br. J. Anaesth."},{"key":"39704_CR10","doi-asserted-by":"publisher","first-page":"1202","DOI":"10.1213\/ane.0000000000001165","volume":"122","author":"Y Li","year":"2016","unstructured":"Li, Y. et al. Dexmedetomidine combined with general anesthesia provides similar intraoperative stress response reduction when compared with a combined general and epidural anesthetic technique. Anesth. Analg. 122, 1202\u20131210. https:\/\/doi.org\/10.1213\/ane.0000000000001165 (2016).","journal-title":"Anesth. Analg."},{"key":"39704_CR11","first-page":"1112","volume":"21","author":"XH Yang","year":"2017","unstructured":"Yang, X. H. et al. Effect of dexmedetomidine on immune function of patients undergoing radical mastectomy: A double blind and placebo control study. Eur. Rev. Med. Pharmacol. Sci. 21, 1112\u20131116 (2017).","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"39704_CR12","doi-asserted-by":"publisher","first-page":"7153","DOI":"10.3892\/ol.2018.8205","volume":"15","author":"K Wang","year":"2018","unstructured":"Wang, K. & Li, C. Effects of dexmedetomidine on inflammatory factors, T lymphocyte subsets and expression of NF-\u03baB in peripheral blood mononuclear cells in patients receiving radical surgery of colon carcinoma. Oncol. Lett. 15, 7153\u20137157. https:\/\/doi.org\/10.3892\/ol.2018.8205 (2018).","journal-title":"Oncol. Lett."},{"key":"39704_CR13","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1067\/msy.2000.103498","volume":"127","author":"K Ogawa","year":"2000","unstructured":"Ogawa, K. et al. Suppression of cellular immunity by surgical stress. Surgery 127, 329\u2013336. https:\/\/doi.org\/10.1067\/msy.2000.103498 (2000).","journal-title":"Surgery"},{"key":"39704_CR14","doi-asserted-by":"publisher","first-page":"972","DOI":"10.1245\/aso.2003.02.007","volume":"10","author":"G Shakhar","year":"2003","unstructured":"Shakhar, G. & Ben-Eliyahu, S. Potential prophylactic measures against postoperative immunosuppression: Could they reduce recurrence rates in oncological patients?. Ann. Surg. Oncol. 10, 972\u2013992. https:\/\/doi.org\/10.1245\/aso.2003.02.007 (2003).","journal-title":"Ann. Surg. Oncol."},{"key":"39704_CR15","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1007\/bf02054059","volume":"39","author":"A Esp\u00ed","year":"1996","unstructured":"Esp\u00ed, A., Arenas, J., Garc\u00eda-Granero, E., Mart\u00ed, E. & Lled\u00f3, S. Relationship of curative surgery on natural killer cell activity in colorectal cancer. Dis. Colon Rectum 39, 429\u2013434. https:\/\/doi.org\/10.1007\/bf02054059 (1996).","journal-title":"Dis. Colon Rectum"},{"key":"39704_CR16","doi-asserted-by":"publisher","first-page":"3747","DOI":"10.1245\/s10434-018-6691-3","volume":"25","author":"L Angka","year":"2018","unstructured":"Angka, L. et al. Natural killer cell IFN\u03b3 secretion is profoundly suppressed following colorectal cancer surgery. Ann. Surg. Oncol. 25, 3747\u20133754. https:\/\/doi.org\/10.1245\/s10434-018-6691-3 (2018).","journal-title":"Ann. Surg. Oncol."},{"key":"39704_CR17","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1016\/j.bbi.2006.12.006","volume":"21","author":"K Greenfeld","year":"2007","unstructured":"Greenfeld, K. et al. Immune suppression while awaiting surgery and following it: Dissociations between plasma cytokine levels, their induced production, and NK cell cytotoxicity. Brain Behav. Immun. 21, 503\u2013513. https:\/\/doi.org\/10.1016\/j.bbi.2006.12.006 (2007).","journal-title":"Brain Behav. Immun."},{"key":"39704_CR18","doi-asserted-by":"publisher","first-page":"1026","DOI":"10.1016\/j.imbio.2012.12.002","volume":"218","author":"S Bae","year":"2013","unstructured":"Bae, S. et al. The effect of alloferon on the enhancement of NK cell cytotoxicity against cancer via the up-regulation of perforin\/granzyme B secretion. Immunobiology 218, 1026\u20131033. https:\/\/doi.org\/10.1016\/j.imbio.2012.12.002 (2013).","journal-title":"Immunobiology"},{"key":"39704_CR19","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1038\/nrc.2015.5","volume":"16","author":"MG Morvan","year":"2016","unstructured":"Morvan, M. G. & Lanier, L. L. NK cells and cancer: You can teach innate cells new tricks. Nat. Rev. Cancer 16, 7\u201319. https:\/\/doi.org\/10.1038\/nrc.2015.5 (2016).","journal-title":"Nat. Rev. Cancer"},{"key":"39704_CR20","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1016\/j.cmet.2018.06.021","volume":"28","author":"J Cong","year":"2018","unstructured":"Cong, J. et al. Dysfunction of natural killer cells by FBP1-induced inhibition of glycolysis during lung cancer progression. Cell Metab. 28, 243-255.e245. https:\/\/doi.org\/10.1016\/j.cmet.2018.06.021 (2018).","journal-title":"Cell Metab."},{"key":"39704_CR21","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1006\/smim.1995.0012","volume":"7","author":"G Trinchieri","year":"1995","unstructured":"Trinchieri, G. Natural killer cells wear different hats: Effector cells of innate resistance and regulatory cells of adaptive immunity and of hematopoiesis. Semin. Immunol. 7, 83\u201388. https:\/\/doi.org\/10.1006\/smim.1995.0012 (1995).","journal-title":"Semin. Immunol."},{"key":"39704_CR22","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1385\/ir:24:2:201","volume":"24","author":"GL Beatty","year":"2001","unstructured":"Beatty, G. L. & Paterson, Y. Regulation of tumor growth by IFN-gamma in cancer immunotherapy. Immunol. Res. 24, 201\u2013210. https:\/\/doi.org\/10.1385\/ir:24:2:201 (2001).","journal-title":"Immunol. Res."},{"key":"39704_CR23","doi-asserted-by":"publisher","first-page":"3209","DOI":"10.1242\/jcs.031187","volume":"122","author":"TJ Shaw","year":"2009","unstructured":"Shaw, T. J. & Martin, P. Wound repair at a glance. J. Cell. Sci. 122, 3209\u20133213. https:\/\/doi.org\/10.1242\/jcs.031187 (2009).","journal-title":"J. Cell. Sci."},{"key":"39704_CR24","doi-asserted-by":"publisher","first-page":"1650","DOI":"10.1056\/nejm198612253152606","volume":"315","author":"HF Dvorak","year":"1986","unstructured":"Dvorak, H. F. Tumors: Wounds that do not heal. Similarities between tumor stroma generation and wound healing. N. Engl. J. Med. 315, 1650\u20131659. https:\/\/doi.org\/10.1056\/nejm198612253152606 (1986).","journal-title":"N. Engl. J. Med."},{"key":"39704_CR25","doi-asserted-by":"publisher","first-page":"e218","DOI":"10.1016\/s1470-2045(12)70582-x","volume":"14","author":"BE Lippitz","year":"2013","unstructured":"Lippitz, B. E. Cytokine patterns in patients with cancer: A systematic review. Lancet Oncol. 14, e218-228. https:\/\/doi.org\/10.1016\/s1470-2045(12)70582-x (2013).","journal-title":"Lancet Oncol."},{"key":"39704_CR26","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1002\/mc.10151","volume":"38","author":"H Bernert","year":"2003","unstructured":"Bernert, H. et al. Tnfa and Il-10 deficiencies have contrasting effects on lung tumor susceptibility: Gender-dependent modulation of IL-10 haploinsufficiency. Mol. Carcinog. 38, 117\u2013123. https:\/\/doi.org\/10.1002\/mc.10151 (2003).","journal-title":"Mol. Carcinog."},{"key":"39704_CR27","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21176009","author":"V Gelfo","year":"2020","unstructured":"Gelfo, V. et al. Roles of IL-1 in cancer: From tumor progression to resistance to targeted therapies. Int. J. Mol. Sci. https:\/\/doi.org\/10.3390\/ijms21176009 (2020).","journal-title":"Int. J. Mol. Sci."},{"key":"39704_CR28","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1016\/s1470-2045(03)01196-3","volume":"4","author":"PW Szlosarek","year":"2003","unstructured":"Szlosarek, P. W. & Balkwill, F. R. Tumour necrosis factor alpha: A potential target for the therapy of solid tumours. Lancet Oncol. 4, 565\u2013573. https:\/\/doi.org\/10.1016\/s1470-2045(03)01196-3 (2003).","journal-title":"Lancet Oncol."},{"key":"39704_CR29","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1007\/s10555-006-9004-4","volume":"25","author":"RN Apte","year":"2006","unstructured":"Apte, R. N. et al. The involvement of IL-1 in tumorigenesis, tumor invasiveness, metastasis and tumor-host interactions. Cancer Metastasis Rev. 25, 387\u2013408. https:\/\/doi.org\/10.1007\/s10555-006-9004-4 (2006).","journal-title":"Cancer Metastasis Rev."},{"key":"39704_CR30","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1016\/j.lungcan.2007.08.005","volume":"59","author":"D Derin","year":"2008","unstructured":"Derin, D. et al. Serum levels of apoptosis biomarkers, survivin and TNF-alpha in nonsmall cell lung cancer. Lung Cancer 59, 240\u2013245. https:\/\/doi.org\/10.1016\/j.lungcan.2007.08.005 (2008).","journal-title":"Lung Cancer"},{"key":"39704_CR31","first-page":"3847","volume":"55","author":"M Huang","year":"1995","unstructured":"Huang, M. et al. Human non-small cell lung cancer cells express a type 2 cytokine pattern. Cancer Res 55, 3847\u20133853 (1995).","journal-title":"Cancer Res"},{"key":"39704_CR32","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1146\/annurev.immunol.19.1.423","volume":"19","author":"K Nakanishi","year":"2001","unstructured":"Nakanishi, K., Yoshimoto, T., Tsutsui, H. & Okamura, H. Interleukin-18 regulates both Th1 and Th2 responses. Annu. Rev. Immunol. 19, 423\u2013474. https:\/\/doi.org\/10.1146\/annurev.immunol.19.1.423 (2001).","journal-title":"Annu. Rev. Immunol."},{"key":"39704_CR33","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1007\/s10555-006-9013-3","volume":"25","author":"F Vidal-Vanaclocha","year":"2006","unstructured":"Vidal-Vanaclocha, F. et al. Clinical and experimental approaches to the pathophysiology of interleukin-18 in cancer progression. Cancer Metastasis Rev. 25, 417\u2013434. https:\/\/doi.org\/10.1007\/s10555-006-9013-3 (2006).","journal-title":"Cancer Metastasis Rev."},{"key":"39704_CR34","doi-asserted-by":"publisher","DOI":"10.3390\/cancers13102297","author":"S Missiroli","year":"2021","unstructured":"Missiroli, S. et al. Targeting the NLRP3 Inflammasome as a new therapeutic option for overcoming cancer. Cancers (Basel) https:\/\/doi.org\/10.3390\/cancers13102297 (2021).","journal-title":"Cancers (Basel)"},{"key":"39704_CR35","doi-asserted-by":"publisher","first-page":"2053","DOI":"10.3892\/or.2016.4569","volume":"35","author":"Y Wang","year":"2016","unstructured":"Wang, Y. et al. Activation of NLRP3 inflammasome enhances the proliferation and migration of A549 lung cancer cells. Oncol. Rep. 35, 2053\u20132064. https:\/\/doi.org\/10.3892\/or.2016.4569 (2016).","journal-title":"Oncol. Rep."},{"key":"39704_CR36","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1038\/ni.1980","volume":"12","author":"K Nakahira","year":"2011","unstructured":"Nakahira, K. et al. Autophagy proteins regulate innate immune responses by inhibiting the release of mitochondrial DNA mediated by the NALP3 inflammasome. Nat. Immunol. 12, 222\u2013230. https:\/\/doi.org\/10.1038\/ni.1980 (2011).","journal-title":"Nat. Immunol."},{"key":"39704_CR37","doi-asserted-by":"publisher","DOI":"10.3390\/biom9110735","author":"V Aggarwal","year":"2019","unstructured":"Aggarwal, V. et al. Role of reactive oxygen species in cancer progression: Molecular mechanisms and recent advancements. Biomolecules https:\/\/doi.org\/10.3390\/biom9110735 (2019).","journal-title":"Biomolecules"},{"key":"39704_CR38","doi-asserted-by":"publisher","first-page":"1002","DOI":"10.1038\/nm.4153","volume":"22","author":"J-S Moon","year":"2016","unstructured":"Moon, J.-S. et al. NOX4-dependent fatty acid oxidation promotes NLRP3 inflammasome activation in macrophages. Nat. Med. 22, 1002\u20131012. https:\/\/doi.org\/10.1038\/nm.4153 (2016).","journal-title":"Nat. Med."},{"key":"39704_CR39","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1038\/ni.1831","volume":"11","author":"R Zhou","year":"2010","unstructured":"Zhou, R., Tardivel, A., Thorens, B., Choi, I. & Tschopp, J. Thioredoxin-interacting protein links oxidative stress to inflammasome activation. Nat. Immunol. 11, 136\u2013140. https:\/\/doi.org\/10.1038\/ni.1831 (2010).","journal-title":"Nat. Immunol."},{"key":"39704_CR40","doi-asserted-by":"publisher","first-page":"763","DOI":"10.2174\/156800911796191051","volume":"11","author":"A Bruzzone","year":"2011","unstructured":"Bruzzone, A. et al. \u03b1(2)-Adrenoceptors enhance cell proliferation and mammary tumor growth acting through both the stroma and the tumor cells. Curr. Cancer Drug Targ. 11, 763\u2013774. https:\/\/doi.org\/10.2174\/156800911796191051 (2011).","journal-title":"Curr. Cancer Drug Targ."},{"key":"39704_CR41","doi-asserted-by":"publisher","first-page":"317","DOI":"10.4103\/joacp.JOACP_299_16","volume":"33","author":"JP Cata","year":"2017","unstructured":"Cata, J. P. et al. Intraoperative use of dexmedetomidine is associated with decreased overall survival after lung cancer surgery. J. Anaesthesiol. Clin. Pharmacol. 33, 317\u2013323. https:\/\/doi.org\/10.4103\/joacp.JOACP_299_16 (2017).","journal-title":"J. Anaesthesiol. Clin. Pharmacol."},{"key":"39704_CR42","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1016\/j.bja.2017.11.004","volume":"120","author":"H Lavon","year":"2018","unstructured":"Lavon, H. et al. Dexmedetomidine promotes metastasis in rodent models of breast, lung, and colon cancers. Br. J. Anaesth. 120, 188\u2013196. https:\/\/doi.org\/10.1016\/j.bja.2017.11.004 (2018).","journal-title":"Br. J. Anaesth."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-39704-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-39704-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-39704-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T10:06:53Z","timestamp":1690884413000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-39704-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8,1]]},"references-count":42,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["39704"],"URL":"https:\/\/doi.org\/10.1038\/s41598-023-39704-3","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,8,1]]},"assertion":[{"value":"1 May 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 July 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 August 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"12471"}}